NCT07618715
Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in U.S. Healthy Participants
Not Yet Recruiting
PHASE1Ages 18–45InterventionalTreatmentNeurodawn Pharmaceutical Co., Ltd.
~11 participants
Updated 2026-06-01 on ClinicalTrials.gov
What's tested:Y-4 tabletPregabalin capsuleRiluzole tablet
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Cmax
Measured over On Day1-4、Day8-11、Day15-18 of observation period.
+2 more outcomes measured
Conditions
NCT07618715
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Frontage Clinical Services,Inc.
Secaucus, New Jerseystudy coordinator listed
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- CmaxOn Day1-4、Day8-11、Day15-18 of observation period.
Maximum observed concentration, it was obtained directly from the measured plasma concentration-time data;
- AUC0-tOn Day1-4、Day8-11、Day15-18 of observation period.
Area under the concentration-time curve from time zero to the last detectable concentration
- AUC0-∞On Day1-4、Day8-11、Day15-18 of observation period.
Area under the concentration-time curve from time 0 to infinity (extrapolated).